Publisher： Karger
E-ISSN： 2296-5262|21|4|1-1
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.21, Iss.4, 1999-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Future Role of Topotecan in the Treatment of Lung Cancer
Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. :
Access to resources
Recommend
New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors
Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. :
Topotecan in the First-Line Treatment of Small-Cell Lung Cancer
Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. :
Potential of Xeloda® in Colorectal Cancer and Other Solid Tumors
Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. :
A Phase I Clinical Trial of Topotecan Given Every 2 Weeks in Patients with Refractory Solid Tumors
Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. :